Lack of trastuzumab activity in nonsmall cell lung carcinoma with overexpression of erb-B2: 39810: A phase II trial of Cancer and Leukemia Group B

Gerald Clamon, James Herndon, Jeffrey Kern, Ramaswamy Govindan, Jennifer Garst, Dorothy Watson, Mark Green

Research output: Contribution to journal › Article › peer-review

109 Scopus citations

Fingerprint

Dive into the research topics of 'Lack of trastuzumab activity in nonsmall cell lung carcinoma with overexpression of erb-B2: 39810: A phase II trial of Cancer and Leukemia Group B'. Together they form a unique fingerprint.

Medicine & Life Sciences